Redwood City, CA · Founded 2021 · Privately Held (backing)
Provider of immuno-oncology therapies intended to activate the innate immune system to fight cancer. Pheast Therapeutics is based in Redwood City, CA and was founded in 2021. It was valued at $155 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $101 million across 2 recorded rounds; the latest was a $24.6 million early-stage round in Oct 2025.
PMV mark · valuation
$154.6M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$100.6M
Last round
Early Stage VC
Oct 2025
Cap table — not yet on record
Pheast Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pheast Therapeutics with a free account
·Watch Pheast Therapeutics: the Monday email on marks, rounds and moves
Where does Pheast Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Pheast Therapeutics's 2 recorded funding rounds.
